Health

  • May 08, 2026

    White House Defends Pardon Process Following Dem Inquiry

    The White House says it has a "rigorous" review process for pardons following an investigation launched by Democrats into possible corruption.

  • May 08, 2026

    Tort Report: Tesla's Legal Exposure Seen As High As $14.5B

    A new report stating that Tesla faces billions in legal liabilities and a $140 million football brain injury verdict against the NCAA lead Law360's Tort Report, which compiles recent personal injury and medical malpractice news that may have flown under the radar.

  • May 08, 2026

    Carbon Health Gets $11M DIP Hike As Mediation Continues

    A Texas bankruptcy judge Friday approved $11 million in additional Chapter 11 financing for urgent care facility operator Carbon Health Technologies as talks continue between parties in the case.

  • May 08, 2026

    Covington, Cooley Lead Drugmaker Odyssey's $279M IPO

    Venture-backed biotechnology firm Odyssey Therapeutics began trading publicly Friday after raising $279 million in its initial public offering, making it the latest biotech to hit the public markets over the last few weeks.

  • May 08, 2026

    Ex-NFL Player Gets 16-Plus Years For $200M Healthcare Fraud

    A Florida federal judge sentenced a former NFL player to more than 16 years in prison for his role in a fraud conspiracy in which he and others bilked government health insurance programs out of nearly $200 million in a scheme using fake doctors' orders for orthotic braces that weren't medically necessary. 

  • May 08, 2026

    Squires Says Yes To 7 Patent Petitions, No To A Dozen More

    U.S. Patent and Trademark Office Director John Squires granted seven petitions for patent review under the America Invents Act and denied 12 other petitions, including a host of challenges by Cisco Systems and Samsung Electronics.

  • May 08, 2026

    Don't Miss It: Paul Hastings, V&E Steer Latest Hot Deals

    A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple weeks, and it's difficult to keep up with all the deals.

  • May 08, 2026

    4th Circ. Backs Toss Of Fired Worker's Whistleblower Suit

    The Fourth Circuit upheld the dismissal Friday of a home health salesperson's suit claiming he was fired out of retaliation for complaining about sexual comments made at a company picnic, ruling the lower court used the correct legal standard to throw out his case.

  • May 08, 2026

    Walgreens Loses Atty Sanctions Bid In Georgia Bias Suit

    The attorney for a former pharmacist suing Walgreens for discrimination has escaped a sanctions bid after a Georgia federal judge found the chain gave the lawyer too little time to respond to a motion to dismiss claims.

  • May 08, 2026

    Using FCA To Go After DEI Poses Legal Hurdles For DOJ

    The Trump administration's use of the False Claims Act to go after DEI policies diverges from past administrations' use of the civil fraud statute to tackle policy initiatives in key ways that may pose legal challenges to enforcement.

  • May 07, 2026

    NC Panel Rules Prior Verdict Bars Hospital Negligence Case

    A divided North Carolina state appeals court panel pulled the plug on a couple's negligence case against a local hospital, finding their suit is bound by a verdict in a separate, near-identical lawsuit in which a jury cleared the same hospital of wrongdoing.

  • May 07, 2026

    9th Circ. Backs Lead Choice In Super Micro Investor Fraud Suit

    A Ninth Circuit panel has refused to undo a California federal court order rejecting Crain Walnut Shelling's bid to lead a securities class action against Super Micro Computers Inc., concluding Thursday the lower court properly determined other investors had shown the nut processor wasn't fit to spearhead the case.

  • May 07, 2026

    La. Says Mailed Abortion Pills Harm State Budget, Sovereignty

    The state of Louisiana on Thursday defended its standing to challenge telehealth access to the abortion medication mifepristone, telling the U.S. Supreme Court that it has suffered financial and other injuries as mail-order pills flood the state.

  • May 07, 2026

    Judge, In 'Difficult Position,' OKs Rare Patent Defense

    A Massachusetts federal judge found himself in what he said was a "difficult position" in allowing an unusual defense to be advanced in a patent infringement case related to blood pumps in light of criticism of the defense from the Federal Circuit.

  • May 07, 2026

    Bayer Sued Over Healthy Sperm Claim On 'One A Day' Pill

    Bayer AG has been hit with a proposed class action in New York federal court alleging that claims on its Men's One A Day Pre-Conception Health Multivitamin supplements misleadingly convey that they could improve chances of conception and support sperm health.

  • May 07, 2026

    Meta Seeks To Toss LA Jury's Social Media Addiction Verdict

    Meta and its Instagram platform asked a Los Angeles judge to override a landmark jury verdict awarding millions of dollars in damages to a woman claiming she became addicted to the social media site as a child, saying in the alternative they deserve a new trial.

  • May 07, 2026

    UK Says Welltower's Senior Home Deals May Hurt Competition

    The United Kingdom's antitrust authority has determined that several of Welltower Inc.'s U.K. senior housing acquisitions create "a realistic prospect of a substantial lessening of competition."

  • May 07, 2026

    California Tribe Seeks Summary Win Over Opioid Clinic Denial

    A California tribe is seeking a summary judgment win after a federal judge rejected its bid for a preliminary injunction to force the Indian Health Service to approve a funding agreement for an opioid treatment clinic, arguing that the agency can't reject the offer because it expands services to non-Indians.

  • May 07, 2026

    Ex‑Novartis Atty Wins Revival Of Whistleblower Claims

    The New Jersey state appeals court on Thursday revived five whistleblower claims brought by a former Novartis compliance attorney, finding that a trial judge wrongly treated a years‑long pattern of alleged retaliation as discrete, time‑barred events rather than a continuous campaign culminating in her 2021 termination.

  • May 07, 2026

    Davis Polk-Led Roche To Pay Up To $1.05B For PathAI

    Davis Polk & Wardwell LLP is advising Roche on a deal announced Thursday that would see the Swiss healthcare company purchase a Boston-based, AI-powered digital pathology company for up to $1.05 billion.

  • May 07, 2026

    King & Spalding Adds Congressional Health Policy Duo In DC

    Two former congressional staffers experienced in health policy recently joined King & Spalding LLP in its Washington, D.C., office, the firm announced this week.

  • May 07, 2026

    GAO Finds Issues With VA's Equipment Maintenance Process

    The U.S. Government Accountability Office said the U.S. Department of Veterans Affairs should do more to ensure that its facilities are getting the best price for the maintenance of its high-tech medical equipment, finding "ineffective" department guidance.

  • May 07, 2026

    New PBGC Amicus Program Offers Input On Important Cases

    Litigants involved in benefits cases that involve novel or significant pension-related issues can now ask the Pension Benefit Guaranty Corp. to lodge briefs shedding light on their disputes, the PBGC announced Thursday.

  • May 07, 2026

    Hospital Suspects DOJ Is Forum Shopping For Trans Records

    Children's Hospital of Philadelphia asked a federal judge this week to reassert control over the U.S. Department of Justice's demand for records of gender-affirming care, fearing the government's withdrawal of its local appeal and a case filed against another hospital in Texas portended "forum shopping" for a friendlier court.

  • May 07, 2026

    Insurer Beats Calif. Health Group's Discovery Costs Suit

    A California federal judge said Wednesday that an insurer did not have to reimburse the state's largest private health foundation for roughly $400,000 in discovery costs it incurred during an executive's now-settled wrongful termination suit, finding the foundation failed to get the insurer's consent before running up the bill.  

Expert Analysis

  • How Cos. Should Prepare For NY RAISE Act Compliance

    Author Photo

    With the New York Responsible AI Safety and Education Act taking effect March 19, state regulators will expect subject artificial intelligence governance policies to understand whether appropriate safeguards and protocols are in place to prevent or mitigate discriminatory or adverse outcomes by frontier models, says Michael Paulino at Gordon Rees.

  • What We Know About DOJ's New FCA Enforcement Priorities

    Author Photo

    Recent remarks from the leader of the Justice Department’s commercial litigation branch provide key insights on how False Claims Act cases — especially healthcare fraud, trade fraud, antidiscrimination and cybersecurity claims — will be evaluated, prioritized and pursued as heightened enforcement becomes the new normal, say attorneys at Latham.

  • The Benefits Of Choosing A Niche Practice In The AI Age

    Author Photo

    As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.

  • How PBMs Can Adapt To Plan Sponsors' Disclosure Demands

    Author Photo

    As federal reforms, growing state regulation and litigation threats push plan sponsors to expect visibility into revenue streams, pharmacy benefit managers should leverage transparency strategically, including by simplifying how they get paid, offering clients audit-ready data and co-designing contracts that are easy for fiduciaries to explain and defend, says Kristie Blase at Frazer + Blase.

  • How To Engage With Gov't's Direct-To-Consumer Drug Policy

    Author Photo

    The U.S. Department of Health and Human Services' recent request for industry input on manufacturers' direct-to-consumer drug sales reflects the government's caution in this arena, and allows stakeholders a rare opportunity to help shape policy, says Mary Kohler at Kohler Health Law.

  • Opinion

    It's Time To Clarify California's Elder Abuse Act

    Author Photo

    As California's elderly population soars, the Golden State's high court and Legislature must provide needed clarification about the scope of the Elder Abuse Act, to resolve the inconsistencies and ambiguities that have impeded the law's ability to remedy elder abuse, neglect and abandonment, say attorneys at Horvitz & Levy.

  • Series

    Podcasting Makes Me A Better Lawyer

    Author Photo

    Podcasting has changed how I ask questions and connect with people, sharpening my ability to listen without interrupting or prejudging, and bringing me closer to what law is meant to be: a human profession grounded in understanding, judgment and trust, says Donna DiMaggio Berger at Becker.

  • When Fraud Involvement Disqualifies FCA Whistleblowers

    Author Photo

    A Massachusetts federal court's recent dismissal of a False Claims Act relator in U.S. ex rel. Perry v. First Psychiatric Planners provides instructive insight into when whistleblowers may be denied their share of settlement proceeds, even if their involvement in the underlying fraud is a step removed, say attorneys at Holland & Knight.

  • Job Shift Accommodation Ruling Clarifies 'Essential Function'

    Author Photo

    In Siebrecht v. Mercy Health-Iowa, the Eighth Circuit's recent denial of a disabled worker's shift exemption request shows that the essential function of a job can encompass more than core job requirements and include things like scheduling flexibility, says Kim Kirn at Miles Mediation & Arbitration.

  • Opinion

    Fed. Circ. Must Bury Design Patent Doctrinal Zombies

    Author Photo

    After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.

  • H-1B Registration Tips For New Wage-Weighted Selection

    Author Photo

    Practitioners participating in this year’s H-1B visa registration, currently underway, must understand that under the new wage-weighted selection process that replaced the random lottery, the crucial first step is choosing the correct standard occupational classification, says Jimmy Lai at Lai & Turner.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

  • Drug Wholesaler's DPA Shows Imperfect Efforts Still Count

    Author Photo

    Atlantic Biologicals’ recent deferred prosecution agreement with federal prosecutors for allegedly distributing controlled substances to pill mill pharmacies demonstrates that even subpar cooperation, when combined with genuine remediation and strategic advocacy, can yield outcomes that protect a company's long-term interests, says Jonathan Porter at Husch Blackwell.

  • Key Takeaways As HRSA Aims To Revive 340B Rebate Pilot

    Author Photo

    The U.S. Department of Health and Human Services' recent request for feedback on the 340B Rebate Model Pilot Program demonstrates that it intends to correct the model's procedural defects, which is positive news for participating manufacturers, but a setback for covered entities, say attorneys at Manatt.

  • Why Mukherji Won't End USCIS' EB-1A Two-Step

    Author Photo

    A Nebraska federal court's recent decision in Mukherji v. Miller seemed to vindicate longstanding complaints about the U.S. Citizenship and Immigration Services' controversial two-step adjudication process, declaring the framework unlawful — but Mukherji is unlikely to be the death blow that immigration practitioners have hoped for, says Jun Li at Reid & Wise.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.